TY  - RPRT
TI  - Real-World Efficacy and Safety of Standard-of-Care Chimeric Antigen Receptor T-Cell (CART) and Bispecific T-Cell Engager (TCE) Therapies in Relapsed/Refractory Multiple Myeloma (RRMM).
AU  - Poy Theprungsirikul
AU  - Rong Wang
AU  - Su-Hsin Chang
AU  - Noffar Bar
AU  - Sabrina Browning
AU  - Terri Parker
AU  - Shi-Yi Wang
AU  - Natalia Neparidze
PY  - 2026
DO  - 10.1111/ejh.70304
UR  - https://pubmed.ncbi.nlm.nih.gov/42676230/
ID  - 42676230
ER  -